{"id":"NCT01095796","sponsor":"Gilead Sciences","briefTitle":"Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults","officialTitle":"A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2011-08","completion":"2014-09","firstPosted":"2010-03-30","resultsPosted":"2012-10-22","lastUpdate":"2015-11-11"},"enrollment":707,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["HIV","HIV Infections"],"interventions":[{"type":"DRUG","name":"Stribild","otherNames":[]},{"type":"DRUG","name":"Atripla","otherNames":[]},{"type":"DRUG","name":"Stribild Placebo","otherNames":[]},{"type":"DRUG","name":"Atripla Placebo","otherNames":[]}],"arms":[{"label":"Stribild","type":"EXPERIMENTAL"},{"label":"Atripla","type":"ACTIVE_COMPARATOR"}],"summary":"To evaluate the safety and efficacy of Stribild®, a single tablet regimen (STR) containing fixed doses of elvitegravir (EVG)/cobicistat (COBI \\[GS-9350\\])/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) versus efavirenz (EFV)/FTC/TDF (Atripla®) in HIV-1 infected, antiretroviral treatment-naive adults. Stribild offers an alternative STR for patients who are not candidates for non-nucleoside reverse transcriptor-based STRs.","primaryOutcome":{"measure":"The Percentage of Participants With Virologic Success Using the Food and Drug Administration (FDA)-Defined Snapshot Analysis as Determined by the Achievement of HIV-1 Ribonucleic Acid (RNA) < 50 Copies/mL at Week 48","timeFrame":"Week 48","effectByArm":[{"arm":"Stribild","deltaMin":87.6,"sd":null},{"arm":"Atripla","deltaMin":84.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":12},"locations":{"siteCount":102,"countries":["United States","Puerto Rico"]},"refs":{"pmids":["22748591","23392460","24256630"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":69,"n":348},"commonTop":["Diarrhoea","Upper respiratory tract infection","Abnormal dreams","Nausea","Dizziness"]}}